BAP31胞内抗体经外泌体microRNA抑制胃癌转移的作用及机制研究
批准号:
31972898
项目类别:
面上项目
资助金额:
52.0 万元
负责人:
王天怡
依托单位:
学科分类:
疫苗、抗体与免疫干预
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
王天怡
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
BAP31在多种肿瘤组织中高表达,促进肿瘤增殖与转移。我们发现BAP31过表达胃癌细胞MKN-45-B31外泌体可以促进内皮细胞增殖、迁移与血管生成;高通量测序MKN-45-B31外泌体microRNA表达谱,发现BAP31可以显著上调miR-21的表达水平,其被报道能够影响肿瘤转移前微环境,促进肿瘤血管生成。我们推测:过表达BAP31的肿瘤细胞通过上调外泌体miR-21的表达,促进转移癌细胞血管生成。在前期研究中我们以BAP31为抗原,从噬菌体抗体库中筛选获得特异性抑制外泌体miR-21表达的抗体F12。本项目将探索F12引起的外泌体miR-21表达抑制对胃癌细胞转移的影响。系统阐明F12经外泌体microRNA途径影响肿瘤转移前微环境及血管生成的分子机制。该研究将为癌症的治疗提供新的可能药物靶点和理论依据,也为拓展胞内抗体技术在癌症治疗领域的应用提供重要的探索思路。
英文摘要
BAP31 is highly expressed in many kinds of tumors and promotes the proliferation and metastasis of tumors. We found that exosome from BAP31 overexpressing gastric cancer cells MKN-45-B31 can promote endothelial cell proliferation, migration and angiogenesis; High-throughput sequencing of MKN-45-B31 exosome microRNA expression profiles showed that BAP31 can significantly up-regulate the expression of miR-21, which has been reported to affect the pre-metastasis microenvironment and promote tumor angiogenesis. We speculate that BAP31 overexpressing cancer cells can promote angiogenesis of metastatic cancer cells by up-regulating the expression of exosome microRNA-21. In previous studies, BAP31 was used as an antigen to screen F12 from a phage antibody library, which specifically inhibited the expression of exosome microRNA-21. This project will explore the effect of F12-induced inhibition of the expression of exosome microRNA-21 on the metastasis of gastric cancer cells and elucidate the molecular mechanism of F12 influencing microenvironment and angiogenesis through exosome microRNA . This study will provide new possible drug targets and theoretical basis for cancer treatment, and also provide important exploration ideas for expanding the application of intracellular antibody technology in the field of cancer treatment.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.3390/ijms241814402
发表时间:2023-09-21
期刊:International journal of molecular sciences
影响因子:5.6
作者:Liu J;Zhang Q;Wang J;Wang C;Lan T;Wang T;Wang B
通讯作者:Wang B
DOI:10.3389/fonc.2023.1056903
发表时间:2023
期刊:Frontiers in oncology
影响因子:4.7
作者:
通讯作者:
DOI:10.3390/ijms241914787
发表时间:2023-09-30
期刊:International journal of molecular sciences
影响因子:5.6
作者:Wang T;Wang C;Wang J;Wang B
通讯作者:Wang B
DOI:10.3390/ijms24087622
发表时间:2023-04-21
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子:5.6
作者:Liu, Jingjing;Zhang, Qi;Wang, Changli;Yang, Jiaying;Yang, Sheng;Wang, Tianyi;Wang, Bing
通讯作者:Wang, Bing
DOI:10.3390/ijms242316740
发表时间:2023-11-25
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子:5.6
作者:Zhang, Qi;Wang, Changli;Wu, Yufei;Liu, Jingjing;Wang, Tianyi;Wang, Bing
通讯作者:Wang, Bing
BAP31胞内抗体的构建及其影响肿瘤干细胞增殖与分化的机制研究
- 批准号:31500754
- 项目类别:青年科学基金项目
- 资助金额:20.0万元
- 批准年份:2015
- 负责人:王天怡
- 依托单位:
国内基金
海外基金















{{item.name}}会员


